Document is current
Any future updates will be listed below
-
Authors
Santos-Peral, Antonio http://orcid.org/0000-0002-2167-5432
Luppa, Fabian
Goresch, Sebastian http://orcid.org/0009-0006-3586-6498
Nikolova, Elena
Zaucha, Magdalena http://orcid.org/0000-0002-3590-1525
Lehmann, Lisa http://orcid.org/0000-0002-5153-3371
Dahlstroem, Frank
Karimzadeh, Hadi http://orcid.org/0000-0003-2264-4395
Thorn-Seshold, Julia http://orcid.org/0000-0002-4879-4159
Winheim, Elena http://orcid.org/0000-0002-0364-662X
Schuster, Ev-Marie
Dobler, Gerhard
Hoelscher, Michael http://orcid.org/0000-0002-7642-1835
Kümmerer, Beate M. http://orcid.org/0000-0002-9011-2764
Endres, Stefan
Schober, Kilian http://orcid.org/0000-0001-9323-9472
Krug, Anne B. http://orcid.org/0000-0002-9556-7207
Pritsch, Michael
Barba-Spaeth, Giovanna http://orcid.org/0000-0003-2069-9501
Rothenfusser, Simon http://orcid.org/0000-0003-1151-7614
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (391217598, 369799452, 391217598, 369799452)
EC | Horizon 2020 Framework Programme (101137459)
Agence Nationale de la Recherche (ANR-17-CE15-0031-01, ANR-17-CE15-0031-01)
Friedrich-Baur-Stiftung
Bundesministerium für Bildung und Forschung (01KI2013, 01KI2013)
- License Information
-
More Information
Article History
Received: 3 July 2023
Accepted: 5 February 2024
First Online: 24 February 2024
Competing interests
: The authors declare no competing interests. This work was supported by FlavImmunity a combined grant of the German Research foundation (DFG) project number 391217598 to SR and ABK and the French National Research Agency (ANR) project number ANR-17-CE15-0031-01 to GBS; by DFG TRR237 grant project number 369799452 to SR and ABK (TRR237 TPB14) and BMK (TRR237 TPA04); by Yellow4Flavi a horizon Europe grant project number 101137459 funded by the European Union to SR, AK GBS, KS; by grants of the iMed consortium of the German Helmholtz Societies to SR; by the Einheit für Klinische Pharmakologie (EKLIP), Helmholtz Zentrum München, Neuherberg, Germany to SR and SE; KS and EMS are supported by the BMBF, project 01KI2013; a Stipend (TI 07.003) by the German Center for Infection Research (DZIF) to FL; grants by the Friedrich Baur Foundation (FBS) to JTS, HK and MP; a Metiphys fellowship of the Medical Faculty of the LMU Munich to MP; by the FöFoLe Program of the Medical Faculty of the LMU Munich to SG, EN, LL, FL, the international doctoral program “iTarget: Immunotargeting of cancer” funded by the Elite Network of Bavaria to ASP, MZ, SG, LL, EN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
